Shuang Tang
FDA investigator
Appears on 1 document from 2015, mostly at sites in Pennsylvania. Most often cites testing and release for distribution (21 CFR 211.165).
- 1
- Documents on file
- 16.0
- Observations per 483
- 2015
- First seen
- 2015
- Most recent
What they cite most
From 16 observations- 21 CFR 211.165Testing and release for distribution3
- 21 CFR 211.160General requirements2
- 21 CFR 211.192Production record review2
- 21 CFR 211.42Design and construction features2
- 21 CFR 211.67Equipment cleaning and maintenance2
- 21 CFR 211.110Sampling and testing of in-process materials and drug products1
Activity by year
2015: 1
Where
Pennsylvania 1
Often inspects with
Is Shuang Tang coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2015-04-17 | 483 Merck Sharp & Dohme LLCApr 17, 2015 · West Point, Pennsylvania | West Point, Pennsylvania | 16 |
About this profile
What does Shuang Tang inspect?
Shuang Tang appears on 1 document on file covering 1 site, mostly in Pennsylvania.
What do they cite most often?
21 CFR 211.165 (testing and release for distribution), followed by 21 CFR 211.160 and 21 CFR 211.192.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Shuang Tang is dated Apr 17, 2015.